Stock Price, News, Quote and Profile of COLLPLANT BIOTECHNOLOGIES LT(NASDAQ:CLGN) stock

COLLPLANT BIOTECHNOLOGIES LT

NASDAQ:CLGN (12/24/2024, 8:03:49 PM)

3.5

+0.06 (+1.74%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryBiotechnology

GICS SubIndustryBiotechnology

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%0%

Sales Q2Q%-100%

CRS8.1

6 Month-29.58%

Overview

Earnings (Last)11-27 2024-11-27/bmo

Earnings (Next)N/A N/A

Ins Owners31.73%

Inst Owners21.38%

Market Cap40.08M

Shares11.45M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts82.5

Short Float %0.09%

Short Ratio0.45

IPO09-01 1993-09-01

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Company Info

COLLPLANT BIOTECHNOLOGIES LT

4 Oppenheimer Street, P.O. Box 4132

Rehovot 7670104

P: 972732325600

CEO: Yehiel Tal

Employees: 75

Website: https://www.collplant.com

CLGN News

a month ago - CollPlantCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

a month ago - CollPlantCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

4 months ago - InvestorPlaceCLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024

CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

4 months ago - BusinessInsiderCLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CollPlant Biotechnologies (NASDAQ:CLGN) just reported results for the second qu...

4 months ago - CollPlantCOLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

4 months ago - CollPlantCollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

/PRNewswire/ -- In a significant step in the advancement of regenerative medicine, CollPlant Biotechnologies (Nasdaq: CLGN) and Stratasys Ltd. (Nasdaq: SSYS)...

COLLPLANT BIOTECHNOLOGIES LT (CLGN)

Nasdaq Stock Screener

USA Stock Screener